Labcorp Holdings Inc. (LON:0JSY)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 15.47B |
| Revenue (ttm) | 10.20B |
| Net Income (ttm) | 565.63M |
| Shares Out | n/a |
| EPS (ttm) | 6.71 |
| PE Ratio | 27.35 |
| Forward PE | 15.24 |
| Dividend | 2.26 (0.91%) |
| Ex-Dividend Date | May 29, 2025 |
| Volume | 370 |
| Average Volume | 146 |
| Open | 247.13 |
| Previous Close | 247.32 |
| Day's Range | 247.13 - 247.13 |
| 52-Week Range | 195.90 - 242.36 |
| Beta | 0.97 |
| RSI | 64.21 |
| Earnings Date | Apr 24, 2025 |
About Labcorp Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target... [Read more]
Financial Performance
In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.
Financial numbers in USD Financial StatementsNews
Labcorp targets 10% EPS growth with new diagnostics and acquisitions strategy
Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript
Labcorp beats quarterly profit estimate on diagnostic test demand
Laboratory operator Labcorp beat analysts' estimate for first-quarter profit on Tuesday, helped by robust demand for its diagnostic tests.
Labcorp Announces 2025 First Quarter Results
Updates Full-Year Guidance Results from Operations for first quarter 2025 versus first quarter last year: Revenue: $3.35 billion versus $3.18 billion Diluted EPS: $2.52 versus $2.69 Adjusted EPS: $3.8...
Earnings Scheduled For April 29, 2025
Companies Reporting Before The Bell • First Commonwealth (NYSE: FCF) is estimated to report quarterly earnings at $0.32 per share on revenue of $117.60 million. • CommVault Systems (NASDAQ: CVLT) is...
Earnings Preview: Laboratory Corp
Laboratory Corp (NYSE: LH) is set to give its latest quarterly earnings report on Tuesday, 2025-04-29. Here's what investors need to know before the announcement. Analysts estimate that Laboratory Co...
LifeMD Acquires Women's Health Provider Optimal Human Health MD to Accelerate Entry into the Women's Health Market
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading provider of virtual primary care services, today announced the acquisition of key assets from Optimal Human Health ...
Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions
Labcorp® Plasma Detect™ now available for clinical use to assess risk of recurrence in stage III colon cancer patients FDA-authorized liquid biopsy assay PGDx elio® plasma focus™ Dx now available to s...
Genetic Screening Testing for the Preventive Health Market, 2025-2035 Analysis - Dominated by Exact Science, Labcorp Genetics, Blueprint Genetics, Ambry Genetics, and Genex Diagnostics
Dublin, April 11, 2025 (GLOBE NEWSWIRE) -- The "Genetic Screening Testing for Preventive Health Market - A Global and Regional Analysis: Focus on Test Type, Technology, Application, End User and Count...
Labcorp Declares Quarterly Dividend
BURLINGTON, N.C. , April 10, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has...
Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease
Labcorp's pTau-217/Beta Amyloid 42 Ratio blood test meets the performance criteria to confirm amyloid pathology consistent with Alzheimer's disease BURLINGTON, N.C. , April 2, 2025 /PRNewswire/ -- Lab...
Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide
New offering expands screening options for cervical cancer and sexually transmitted infections (STIs), including chlamydia, gonorrhea, trichomonas or mycoplasma genitalium (Mgen) BURLINGTON, N.C. , Ap...
Labcorp to Announce First Quarter Financial Results on April 29, 2025
BURLINGTON, N.C. , March 31, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the firs...
Labcorp to buy certain assets of OPKO unit BioReference Health
Labcorp (NYSE:LH) stock gains after deal to acquire OPKO Health (OPK) unit BioReference Health's cancer-focused units for up to $225M. Read more here.
Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
Transaction to extend Labcorp's leadership in oncology and expand access to the company's high-quality clinical laboratory services BURLINGTON, N.C. and MIAMI , March 11, 2025 /PRNewswire/ -- Labcorp ...
Charles River, LabCorp upgraded, Quest downgraded at Citi on valuation
Is the Market Bullish or Bearish on Labcorp Hldgs?
Labcorp Hldgs's (NYSE: LH) short percent of float has fallen 3.63% since its last report. The company recently reported that it has 1.83 million shares sold short , which is 2.92% of all regular shar...
Insider Sell: van der Vaart Sandra D Sells 1,314 Shares of Labcorp Holdings Inc (LH)
Insider Sell: van der Vaart Sandra D Sells 1,314 Shares of Labcorp Holdings Inc (LH)
Insider Sell: Amy Summy Sells Shares of Labcorp Holdings Inc (LH)
Insider Sell: Amy Summy Sells Shares of Labcorp Holdings Inc (LH)
Decoding Labcorp Holdings Inc (LH): A Strategic SWOT Insight
Decoding Labcorp Holdings Inc (LH): A Strategic SWOT Insight
Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors
Labcorp® Plasma CompleteTM offers oncologists a highly sensitive and specific genomic profiling solution from a simple blood draw BURLINGTON, N.C. , Feb. 24, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a...
Labcorp Holdings: Focus On Core Strengths For Future Growth, Initiate At 'Hold'
Labcorp Holdings Inc., a leader in life sciences and diagnostics, is efficiently managing its financials and focusing on core strengths for long-term growth, warranting a “Hold” rating. Competitive ad...
Labcorp targets 2025 EPS growth of up to 10% with expanding margins
Labcorp Holdings Inc. (LH) Q4 2024 Earnings Call Transcript
Labcorp Holdings Inc. (NYSE:LH) Q4 2024 Earnings Conference Call February 6, 2025 9:00 AM ETCompany ParticipantsChristian O'Donnell - IRAdam Schechter -...
Labcorp Q4 Earnings: Revenue And EPS Beat, Expects Strong 2025 Growth, Analyst Reiterates Outperform On Stable 2025 Outlook
Thursday, Laboratory Corp (NYSE: LH) reported fourth-quarter 2024 adjusted earnings per share of $3.45, up from $3.30 a year ago, beating the consensus of $3.39 . Sales increased 9.8% year-over-year t...